Tinidazole warnings and precautions

Tinidazole

TINDAMAX® FDA Package Insert
Description
Clinical Pharmacology
Microbiology
Indications and Usage
Contraindications
Warnings and Precautions
Adverse Reactions
Drug Interactions
Overdosage
Dosage and Administration
Clinical Studies
How Supplied
Labels and Packages

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:  Ahmed Zaghw, M.D. [2]

## Warnings and Precautions

[edit | edit source]

### Neurological Adverse Reactions

[edit | edit source]

Convulsive seizures and peripheral neuropathy, the latter characterized mainly by numbness or paresthesia of an extremity, have been reported in patients treated with tinidazole. The appearance of abnormal neurologic signs demands the prompt discontinuation of tinidazole therapy.

### Vaginal Candidiasis

[edit | edit source]

The use of tinidazole may result in Candida vaginitis. In a clinical study of 235 women who received tinidazole for bacterial vaginosis, a vaginal fungal infection developed in 11 (4.7%) of all study subjects [see Clinical Studies (14.5)].

### Blood Dyscrasia

[edit | edit source]

Tinidazole should be used with caution in patients with evidence of or history of blood dyscrasia [see Drug Interactions (7.3)].

### Drug Resistance

[edit | edit source]

Prescribing Tindamax in the absence of a proven or strongly suspected bacterial infection or a prophylactic indication is unlikely to provide benefit to the patient and increases the risk of the development of drug-resistant bacteria.[1]

## References

[edit | edit source]

1. ↑ "TINDAMAX (TINIDAZOLE) TABLET, FILM COATED [MISSION PHARMACAL COMPANY]".

Adapted from the FDA Package Insert.